Literature DB >> 3745963

Studies on the mechanism of systemic suppression of contact hypersensitivity by UVB radiation. II. Differences in the suppression of delayed and contact hypersensitivity in mice.

M L Kripke, W L Morison.   

Abstract

Exposing mice to UV radiation in the UVB range (280-320 nm) causes a selective immune suppression that contributes to the development of UVB-induced skin cancers. Among the immune responses suppressed by UVB irradiation are contact and delayed hypersensitivity reactions to haptens administered at unexposed sites. In these studies we provide evidence that delayed and contact hypersensitivity to the same hapten are not equivalent reactions and that they are suppressed in UVB-irradiated mice by 2 different mechanisms. This conclusion is based on the findings that: suppression of contact hypersensitivity could not be overcome by immunizing UVB-irradiated mice with hapten-coupled antigen-presenting cells derived from normal donors; and treatment of UVB-irradiated mice with methylprednisolone before immunization prevented the suppression of delayed hypersensitivity but had no effect on the suppression of contact hypersensitivity. The decreased ability to induce contact hypersensitivity in UVB-irradiated mice could be transferred to x-irradiated mice by reconstituting them with spleen cells from UVB-irradiated donors. The induction of hapten-specific suppressor cells, however, required both UVB irradiation and priming with hapten. Based on these results, we postulate that UVB irradiation induces a population of suppressor-inducer cells with specificity for a modified skin antigen and that this antigen serves as a carrier molecule for haptens that induce contact hypersensitivity and for tumor-specific transplantation antigens on UVB-induced tumors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3745963     DOI: 10.1111/1523-1747.ep12355000

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis.

Authors:  S Grabbe; M Steinert; K Mahnke; A Schwartz; T A Luger; T Schwarz
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

Review 2.  Advances in the immunobiology of the skin. Implications for cutaneous malignancies.

Authors:  C A Romerdahl; M L Kripke
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

3.  Pilot study of the effect of ultraviolet light on pain and mood in fibromyalgia syndrome.

Authors:  Sarah L Taylor; Mandeep Kaur; Kristen LoSicco; Joy Willard; Fabian Camacho; Kenneth S O'Rourke; Steven R Feldman
Journal:  J Altern Complement Med       Date:  2009-01       Impact factor: 2.579

4.  Activation of protein kinase CK2 is an early step in the ultraviolet B-mediated increase in interstitial collagenase (matrix metalloproteinase-1; MMP-1) and stromelysin-1 (MMP-3) protein levels in human dermal fibroblasts.

Authors:  Peter Brenneisen; Meinhard Wlaschek; Edith Schwamborn; Lars-Alexander Schneider; Wenjian Ma; Helmut Sies; Karin Scharffetter-Kochanek
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

5.  Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice.

Authors:  M L Kripke; P A Cox; L G Alas; D B Yarosh
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 6.  Photoaging: UV radiation-induced inflammation and immunosuppression accelerate the aging process in the skin.

Authors:  Antero Salminen; Kai Kaarniranta; Anu Kauppinen
Journal:  Inflamm Res       Date:  2022-06-24       Impact factor: 6.986

7.  UV-B exposure impairs resistance to infection by Trichinella spiralis.

Authors:  W Goettsch; J Garssen; A Deijns; F R de Gruijl; H van Loveren
Journal:  Environ Health Perspect       Date:  1994-03       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.